Skip to main content

$0.860 0.010 (1.18%)

High

$0.88

Low

$0.86

Trades

19

Turnover

$55,369

Volume

64,140
30 June 2023 at 3:08pm
Register to track PIQ and receive email alerts.
Subject
PIQ Ann: Sonic Healthcare USA signs licence for PromarkerD in the US

PIQ Ann: Trading Halt

PIQ Ann: World Endometriosis Congress - New diagnostic test showcased

PIQ Ann: Canagliflozin lowers PromarkerD DKD risk prediction scores

PIQ Ann: Notification of cessation of securities - PIQ

PIQ Ann: Exercise of Options

PIQ Ann: Application for quotation of securities - PIQ

PIQ Ann: March 2023 Quarterly Activities Report and Appendix 4C

PIQ Ann: Clinical Advisory Board expanded for PromarkerD USA rollout

PIQ Ann: Proteomics renews ISO 13485 and ISO 17025 accreditations

PIQ Ann: Notification of cessation of securities - PIQ

PIQ Ann: Exercise of Options

PIQ Ann: Application for quotation of securities - PIQ

PIQ Ann: New endometriosis test presented at international conference

PIQ Ann: Trading Halt

PIQ Ann: Exercise of Options

PIQ Ann: Application for quotation of securities - PIQ

PIQ Ann: Proteomics International Webinar and Q&A

PIQ Ann: PromarkerD application for Australian MBS to be resubmitted

PIQ Ann: US update - PromarkerD licensing negotiations

PIQ Ann: Appendix 4D and Interim Financial Report

PIQ Ann: Distribution agreement for PromarkerD in Britain extended

PIQ Ann: Exercise of Options

PIQ Ann: Application for quotation of securities - PIQ

PIQ Ann: Exercise of Options

PIQ Ann: Application for quotation of securities - PIQ

PIQ Ann: Investor presentation - Euroz Hartleys Healthcare Forum

PIQ Ann: December 2022 Quarterly Activities Report and Appendix 4C

PIQ Ann: Letter of intent with Sonic Healthcare USA extended

PIQ Ann: Exercise of Options

PIQ Ann: Application for quotation of securities - PIQ

PIQ Ann: Exercise of Options

PIQ Ann: Application for quotation of securities - PIQ

PIQ Ann: Exercise of Options

PIQ Ann: Application for quotation of securities - PIQ

PIQ Ann: Letter of intent with Sonic Healthcare USA extended

PIQ Ann: CPT PLA reimbursement code approved in US for PromarkerD

PIQ Ann: UK NICE publishes Medtech Innovation Briefing on PromarkerD

PIQ Ann: Change of Directors' Interest Notices

PIQ Ann: Notification regarding unquoted securities - PIQ

PIQ Ann: Completion of Tranche 2 of Placement

PIQ Ann: Application for quotation of securities - PIQ

PIQ Ann: New Constitution

PIQ Ann: Results of Meeting

PIQ Ann: AGM Chairman's Address and Investor Presentation

PIQ Ann: Notification regarding unquoted securities - PIQ

PIQ Ann: Issue of Equity Incentives to Employees

PIQ Ann: PromarkerD patent granted in Hong Kong

PIQ Ann: Investor Presentation to the Emerging ASX Gems Conference

PIQ Ann: Proteomics to present at the Emerging ASX Gems Conference

Register to track PIQ and receive email alerts.

Similar Companies

ADO
BPH
CTE
GSS
GTG
MEM
OSL
PAL